Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by, and welcome to the Acutus Medical Second Quarter 2023 Earnings Conference Call.
Acutus Medical Inc. (AFIB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 2,660,808 | $500,232 | 0% | |
| 2. | OrbiMed Advisors Samuel Isaly | 2,648,386 | $497,897 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 347,800 | $65,000 | +7% | 0% |
| 4. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 40,000 | Director | 52,911 | 2021-11-15 | Filing | |
| $14.00 | 357,143 | Large Shareholder, Director | 1,677,361 | 2021-07-19 | Filing | |
| $14.00 | 714,285 | Large Shareholder, Director | 4,872,025 | 2021-07-19 | Filing | |
| $14.00 | 357,143 | Large Shareholder, Director | 1,677,361 | 2021-07-19 | Filing | |
| $14.00 | 714,285 | Large Shareholder, Director | 4,872,025 | 2021-07-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.58 | 60,000 | Director | 507,509 | 2022-06-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 286,084 | $57,761 | 0% | |
| 2. | 206,624 | $41,733 | 0% | |
| 3. | 206,681 | $41,729 | 0% | |
| 4. | 51,871 | $10,473 | 0% | |
| 5. | 35,038 | $7,074 | 0% |
News See All
Acutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for standing by. Welcome to the Acutus Medical First Quarter 2023 Conference Call.
Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Acutus Medical's Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Is It Too Late to Buy Acutus Medical (AFIB) Stock?
Baron Discovery Fund recently published its first-quarter commentary – a copy of which can be downloaded here.
Is AFIB A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Acutus Medical, Inc. (NASDAQ:AFIB) and determine whether it is a good investment right now.
Is Acutus Medical (AFIB) a Smart Long-term Buy?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Billionaire Hedge Funds
